Posted on March 26, 20213/26/21
Italy’s AGCM Proposes Increased Public-Private Integration, Scrapping Laws that Prohibit Competition Among Biosimilars, Generics
Posted on March 25, 20213/25/21
Sanders’ 3 Acts Latest Entry in United States’ Prescription Drug Price Saga
Posted on March 24, 20213/24/21
Chengdu Launches Rare Disease Drug Program with Capped Reimbursement
Posted on March 24, 20213/24/21
EU Set to Tighten Vaccine Export Restrictions, Cutting Supplies to UK for 6 Weeks
Posted on March 24, 20213/24/21
Dubai Introduces New Unified Formerly SHIFA
Posted on March 22, 20213/22/21
On AMNOG’s 10th Anniversary, G-BA’s Hecken Questions Whether 1-Year Free Pricing Is Too Long
Posted on March 19, 20213/19/21
EUCOPE Calls for Additional Considerations in Joint EU HTA Discussions
Posted on March 18, 20213/18/21
Italy Reimburses Zolgensma Through “Payment at Result” Model, Priced at EUR 2.155 M
Posted on March 17, 20213/17/21
EMA ‘Firmly Convinced’ of AZ Vaccine Safety Ahead of Official Review Results
Posted on March 16, 20213/16/21